Drugs / Phentermine/Topiramate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05579249 Comparator | Jan 2023 → Nov 2024 | obesity disorder | Novo Nordisk A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phentermine/Topiramate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05579249 ↗ |
| Route | Oral | “phentermine/topiramate extended release p.o.” NCT05579249 ↗ |